Biden administration will re-negotiate top 10 Medicare costly drugs - this includes two of interest to rheumatologists
1. Stelara (ustekinumab) - avg Part D Rx cost = $119,951
2. Enbrel (etanercept) - avg Pt D Rx cost = $58,148
https://t.co/HuXmFodZfd https://t.co/BuGl34Zpv5 https://t.co/uniQoEywDB
Links:
FACT SHEET: Biden-Harris Administration Announces First Ten Drugs Selected for …
https://bit.ly/48PUuXT
Big Pharma’s American Con
https://bit.ly/3HE7zru
Jan-30-2024
